Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedPal AI's total inventories for the quarter that ended in Feb. 2026 was £0.22 Mil. MedPal AI's average total inventories from the quarter that ended in Aug. 2025 to the quarter that ended in Feb. 2026 was £0.11 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. MedPal AI's Net-Net Working Capital per share for the quarter that ended in Feb. 2026 was £-0.00.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
MedPal AI's Days Inventory for the
six
months ended in Feb. 2026 was 15.89.
Inventory Turnover measures how fast the company turns over its inventory within a year.
MedPal AI's Inventory Turnover for the quarter that ended in Feb. 2026 was 11.49.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MedPal AI's Inventory-to-Revenue for the quarter that ended in Feb. 2026 was 0.07.
MedPal AI (LSE:MPAL) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
MedPal AI's Net-Net Working Capital Per Share for the quarter that ended in Feb. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MedPal AI's Inventory to Revenue for the quarter that ended in Feb. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
MedPal AI Total Inventories Related Terms
MedPal AI Total Inventories Historical Data
* Premium members only.
The historical data trend for MedPal AI's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
MedPal AI (LSE:MPAL) has a Total Inventories of £0.22 Mil as of Feb. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for MedPal AI and its competitors.
Is MedPal AI's Total Inventories too high?
MedPal AI's current Total Inventories is £0.22 Mil.
How does MedPal AI's Total Inventories compare to VEEV and BTSG?
MedPal AI's Total Inventories of £0.22 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Healthcare Providers & Services company?
A good Total Inventories depends on the Healthcare Providers & Services industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for MedPal AI and its competitors. MedPal AI's current Total Inventories is £0.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current Total Inventories of £0.22 Mil. The current Total Inventories is £0.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current Total Inventories is £0.22 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:MPAL has been successfully added to your 
